John Brancaccio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John brancaccio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Brancaccio Today - Breaking & Trending Today

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday? - Hepion Pharmaceuticals (NASDAQ:HEPA)

Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives. ....

John Brancaccio , Hepion Pharmaceuticals Inc , Hepion Pharmaceuticals , Executive Chairman ,

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Friday, Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) said it has begun winding down activities in its ASCEND-NASH Trial while continuing to explore strategic alternatives, as announced in December 2023. ASCEND-NASH is a Phase 2b, randomized, multicenter, double-blinded study with the first patient screened in August 2022 to evaluate the safety and efficacy of rencofilstat dosed for 12 months, with a target enrollment of 336 subjects. Enrollment was paused in April 2023, with 151 subjects randomized ....

John Brancaccio , Hepion Pharmaceuticals Inc , Hepion Pharmaceuticals , Executive Chairman , Stock Market Game , Benzinga Pro , Day Trial ,

Hepion ends Phase 2 study for NASH drug due to cash restraints (NASDAQ:HEPA)

Hepion ends Phase 2 study for NASH drug due to cash restraints (NASDAQ:HEPA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

John Brancaccio , Sagimet Biosciences , Hepion Pharmaceuticals , Madrigal Pharmaceuticals , Human Liver Anatomy , Hepion Executive Chairman John Brancaccio , Eli Lilly , Novo Nordisk , Viking Therapeutics , Akero Therapeutics , Galectin Therapeutics , Terns Pharma ,

Hepion Pharmaceuticals (HEPA) Winds Down Activities in Phase 2b 'ASCEND-NASH' Trial

Hepion Pharmaceuticals (HEPA) Winds Down Activities in Phase 2b 'ASCEND-NASH' Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John Brancaccio , Hepion Pharmaceuticals Inc , Hepion Pharmaceuticals , Executive Chairman ,

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John Brancaccio , Hepion Pharmaceuticals Inc , Exchange Commission , Hepion Pharmaceuticals , Drug Administration , Executive Chairman , Fast Track , Orphan Drug , Artificial Intelligence , Private Securities Litigation Reform Act , Hepion Pharmaceutical , Hepion Pharmaceutical Form ,